How plants fine-tune their natural chemical defenses
La Jolla, CA – Even closely related plants produce their own natural chemical cocktails, each set uniquely adapted to the individual plant's specific habitat. Comparing anti-fungals produced by tobacco and henbane, researchers at the Salk Institute for Biological Studies discovered that only a few mutations in a key enzyme are enough to shift the whole output to an entirely new product mixture. Making fewer changes led to a mixture of henbane and tobacco-specific molecules and even so-called "chemical hybrids," explaining how plants can tinker with their natural chemical factories and adjust their product line to a changing environment without shutting down intracellular chemical factories completely.
The findings not only gave the Salk scientists a glimpse of the plants' evolutionary past, but may help them fine-tune the production of natural and environmentally friendly fungicides and pesticides as well as new flavors and fragrances by turning "enzymatic knobs" in the right direction.
Trying to make the best of their real estate, plants rely on an impressive arsenal of volatile and nonvolatile molecules, which diffuse easily through the membranes of the cells that produce them to communicate and interact with the outside world. Often highly aromatic and exceedingly specific for a particular ecological niche, these chemicals attract pollinators, summon natural predators of pests, defend against competitors or, through their antimicrobial properties, protect against natural plant pathogens such as fungi and bacteria.
"Most people are familiar with the word biodiversity, but 'chemodiversity,' – the extraordinary tapestry of natural chemicals found in plants – is just as important for life, the appearance of new species and the survival of many different ecosystems on the earth," says Howard Hughes Medical Institute investigator Joseph P. Noel, Ph.D, director of the Jack H. Skirball Center for Chemical Biology and Proteomics, who led the study, which was published ahead of print in the Sept. 7 online edition of Nature Chemical Biology.
For centuries, mankind has exploited this vast reservoir of natural chemicals for the discovery of new pharmaceuticals to treat disease. "Understanding the chemistry and evolutionary principles that underlie this extraordinary biological diversity will show us how to alter biosynthetic pathways to equip crops with natural and environmentally friendly defenses against pests and diseases, to produce new pharmaceuticals, to enhance levels of naturally occurring health-promoting nutrients or to speed up plant adaptation in the face of global climatic change," hopes Noel.
For the current study, postdoctoral researcher and first author Paul O'Maille, Ph.D., probed the metabolic pathways that members of the nightshade family, which includes tobacco, tomatoes, potatoes, peppers and henbane, use to produce terpenes – compounds that impart aromatic odors and flavors to foods. In many cases, they are also modified in the plant to produce so-called phytoalexins, which are natural forms of anti-fungal and antimicrobial compounds found in many different plants.
Henbane (Hyoscyamus muticus) and tobacco (Nicotiana tabacum) each rely on a different phytoalexin to successfully defend themselves against fungi typical for their habitat. Yet the more than 500 amino acids that make up the chemical factories in each – known as sesquiterpene synthases – are nearly identical to each other, with very minor differences accumulated over approximately several million years of evolutionary change. Using structural analyses, O'Maille and his colleagues had earlier discovered that changing only 9 of the 550 amino acids shifts the production from tobacco-specific phytoalexins to the henbane versions and vice versa.
This time, they were trying to understand the many possible roads that cross the evolutionary divide between tobacco and henbane sesquiterpene synthases. O'Maille created a gene library that encoded all possible amino acid combinations, 512 in total, and produced and analyzed the mutant proteins, paying specific attention to the chemical output and efficiency of each enzyme. "This was the first systematic effort to link DNA sequence variation with chemical complexity," says O'Maille.
This first glimpse revealed a rugged landscape of catalytic activities, where small changes gradually shift the equilibrium between both phytoalexins and in some cases cause rapid evolutionary jumps. "It isn't the specific amino acid change that's important but rather the genetic context in which it occurs," says O'Maille.
Now the Salk researchers are planning to extend their studies to other members of the nightshade family, including tomato, potato, pepper and eggplant, to see how the simplified laboratory system is recapitulated by Mother Nature.
"This latter much larger study will take us all over the globe to sample organisms and ecosystems harboring this large family of agriculturally important plants," says Noel, who predicts that "it is almost certain that our highly simplified experimental system just published will undergo revision as we peel back the layers of time and begin to understand the enormous biochemical potential of the plant kingdom."
Researchers who also contributed to the study include interns Arthur Malone and Iseult Sheehan and graduate student Nikki Dellas in the Noel lab; Professor B. Andes Hess Jr., Ph.D., Department of Chemistry at Vanderbilt University in Nashville; Professor Lidia Smentek, Ph.D., Institute of Physics, Nicolaus Copernicus University, Torun, Poland; research scientist Bryan T. Greenhagen, Ph.D., Microbia Precision Engineering; Professor Joe Chappell, Ph.D., in the Department of Plant and Soil Sciences at the University of Kentucky in Lexington; and Gerard Manning, Ph.D., director of the Razavi Newman Center for Bioinformatics at the Salk Institute.
The Salk Institute for Biological Studies in La Jolla, California, is an independent nonprofit organization dedicated to fundamental discoveries in the life sciences, the improvement of human health and the training of future generations of researchers. Jonas Salk, M.D., whose polio vaccine all but eradicated the crippling disease poliomyelitis in 1955, opened the Institute in 1965 with a gift of land from the City of San Diego and the financial support of the March of Dimes.